However, the label says aducanumab is indicated for the treatment of Alzheimer’s, based on reduction in beta-amyloid plaques, one of the hallmarks of the disease. The FDA is not requiring any specific diagnostic test. What type of diagnostic test is the FDA requiring? There is no evidence that aducanumab can restore lost memories or cognitive function. Will this drug restore memories or cognitive function that has been lost? Its removal may also help other processes in your brain to operate more efficiently. The brain goes on creating beta-amyloid, but aducanumab decreases the amount. How does aducanumab work?Īducanumab is designed to target and remove specific forms of beta-amyloid that accumulate into plaques, which may contribute to cell death and tissue loss in areas of the brain particularly important for memory, thinking, learning and behaviors. There is no safety or effectiveness data on initiating treatment at earlier or later stages of the disease than were studied.
Treatment with aducanumab may be appropriate for people in the disease stage studied in the clinical trials.
The drug was studied in people living with early Alzheimer’s disease - which includes people with mild cognitive impairment (MCI) or mild dementia due to Alzheimer's disease who also have evidence of a buildup of amyloid plaques in the brain.
#FLUID MASK 3 TRIAL DOWNLOAD#
Download Who should take this drug?Īducanumab is indicated for the treatment of Alzheimer’s disease. Effective communication with care team members - particularly health care providers - is critical to ensure that the person living with dementia receives the best possible care.
0 kommentar(er)
